Trial intelligence / Profile preview

Clozapine vs Olanzapine in Childhood Onset Psychotic Disorders

NCT00001656Phase 4Completed

Sponsor
National Institute of Mental Health
Start
Jun 1997
Primary completion
Jun 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in schizophrenia, psychotic disorder and schizoaffective disorder comparing Olanzapine with Clozapine (2 arms). Primary endpoints: Scale for the Assessment of Negative Symptoms at 8 weeks, Clinical Global Impression Severity of Symptoms Scale at 8 weeks and 6 more. Started Jun 1997; status: completed.

02

Drugs

clozapineolanzapine
03

Conditions

schizophreniapsychotic disorderschizoaffective disorder

Beyond the preview

Go deeper on NCT00001656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call